LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry (WEARIT-III)
Prospective Registry of Patients With Ischemic Heart Failure Using the LifeVest Wearable Cardioverter Defibrillator (WEARIT-III)
Sponsor: University of Rochester
A observational or N/A phase clinical study on Ischemic Heart Failure, this trial is completed. The trial is conducted by University of Rochester and has accumulated 11 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Feb 2020 — Jan 2021 [monthly]
Completed
-
Apr 2019 — Feb 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 6 earlier versions
-
Jun 2018 — Apr 2019 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2017 — Mar 2018 [monthly]
Recruiting NA
-
Feb 2017 — Sep 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Rochester
- Zoll Medical Corporation
For direct contact, visit the study record on ClinicalTrials.gov .